These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 30226950)

  • 21. [The Application Study of Voriconazole and Its Metabolites Concentration Monitoring in Allogeneic Hematopoietic Stem Cell Transplantation Patients].
    Wang HC; Wang L; Li M; Shi L; Sun HH; Liu HX; Ou HL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Jun; 32(3):945-951. PubMed ID: 38926993
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Scedosporium apiospermum infectious scleritis following posterior subtenon triamcinolone acetonide injection: a case report and literature review.
    Todokoro D; Hoshino J; Yo A; Makimura K; Hirato J; Akiyama H
    BMC Ophthalmol; 2018 Feb; 18(1):40. PubMed ID: 29433463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decrease of voriconazole trough levels during therapy with enteral nutrition: a case report.
    Kaneko H; Yamazaki S; Uchida M; Suzuki T; Murakami K; Matsubara H; Kamei K; Ishii I
    J Pharm Health Care Sci; 2022 Feb; 8(1):6. PubMed ID: 35109934
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of polymorphisms of pharmacokinetics-related genes and the inflammatory response on the metabolism of voriconazole.
    Aiuchi N; Nakagawa J; Sakuraba H; Takahata T; Kamata K; Saito N; Ueno K; Ishiyama M; Yamagata K; Kayaba H; Niioka T
    Pharmacol Res Perspect; 2022 Apr; 10(2):e00935. PubMed ID: 35199485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evaluation of voriconazole oral dosage in Japan].
    Hamada Y; Kawasumi N; Hirai J; Yamagishi Y; Mikamo H
    Jpn J Antibiot; 2014 Oct; 67(5):279-84. PubMed ID: 25566590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative study of prophylaxis with high and low doses of voriconazole in children with malignancy.
    L Kandaurava S; S Baslyk K; A Migas A; V Hill A; I Bydanov O; A Mishkova V; V Aleinikova O
    Curr Med Mycol; 2020 Dec; 6(4):27-34. PubMed ID: 34195457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trends in Implementation of Loading Dose of Voriconazole from 2010 to 2019 and Influencing Factors of Loading Dose Based on a Japanese Administrative Claim Database: A Retrospective Cohort Study.
    Inose R; Goto R; Shimoki M; Ohmagari N; Muraki Y
    Biol Pharm Bull; 2023; 46(12):1838-1841. PubMed ID: 38044104
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial.
    Maertens JA; Raad II; Marr KA; Patterson TF; Kontoyiannis DP; Cornely OA; Bow EJ; Rahav G; Neofytos D; Aoun M; Baddley JW; Giladi M; Heinz WJ; Herbrecht R; Hope W; Karthaus M; Lee DG; Lortholary O; Morrison VA; Oren I; Selleslag D; Shoham S; Thompson GR; Lee M; Maher RM; Schmitt-Hoffmann AH; Zeiher B; Ullmann AJ
    Lancet; 2016 Feb; 387(10020):760-9. PubMed ID: 26684607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential effects of C-reactive protein levels on voriconazole metabolism at three age groups in allogeneic hematopoietic cell transplant recipients.
    Luo X; Li T; Hu L; Liu S; Zhao H; Zhang J; Feng Y; Huang L
    J Chemother; 2021 Apr; 33(2):95-105. PubMed ID: 32441568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk Factors for Voriconazole-Associated Hepatotoxicity in Patients in the Intensive Care Unit.
    Wang Y; Wang T; Xie J; Yang Q; Zheng X; Dong W; Xing J; Wang X; Dong Y
    Pharmacotherapy; 2016 Jul; 36(7):757-65. PubMed ID: 27284960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful treatment of Beauveria bassiana fungal keratitis with topical voriconazole.
    Ogawa A; Matsumoto Y; Yaguchi T; Shimmura S; Tsubota K
    J Infect Chemother; 2016 Apr; 22(4):257-60. PubMed ID: 26603426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Voriconazole therapeutic drug monitoring: results of a prematurely discontinued randomized multicenter trial.
    Neofytos D; Ostrander D; Shoham S; Laverdiere M; Hiemenz J; Nguyen H; Clarke W; Brass L; Lu N; Marr KA
    Transpl Infect Dis; 2015 Dec; 17(6):831-7. PubMed ID: 26346408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of antifungal stewardship using therapeutic drug monitoring in voriconazole therapy on the prevention and control of hepatotoxicity and visual symptoms: A multicentre study conducted in Japan.
    Hamada Y; Ueda T; Miyazaki Y; Nakajima K; Fukunaga K; Miyazaki T; Nakada-Motokawa N; Nagao M; Kawamura H; Shigemi A; Ebihara F; Kimura T; Ikegame K; Uchino M; Ikeuchi H; Takesue Y
    Mycoses; 2020 Aug; 63(8):779-786. PubMed ID: 32510723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Severe neurological disorders and refractory aspergillosis in an adolescent treated by vincristine and voriconazole.
    Bennis Y; Bodeau S; Lutun A; Gourmel A; Solas C; Quaranta S; Guillaume N; Chouaki T; Lemaire-Hurtel AS; Masmoudi K
    J Clin Pharm Ther; 2018 Apr; 43(2):265-268. PubMed ID: 28795412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selection of Oral Antifungals for Initial Maintenance Therapy in Chronic Pulmonary Aspergillosis: A Longitudinal Analysis.
    Tashiro M; Takazono T; Saijo T; Yamamoto K; Imamura Y; Miyazaki T; Kakeya H; Ando T; Ogawa K; Kishi K; Tokimatsu I; Hayashi Y; Fujiuchi S; Yanagihara K; Miyazaki Y; Ichihara K; Mukae H; Kohno S; Izumikawa K
    Clin Infect Dis; 2020 Feb; 70(5):835-842. PubMed ID: 30959519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Voriconazole Induced Hallucinations and Visual Disturbances in a Female Child: A Case Report and Literature Review.
    Zheng R; Li Y; Guo C; Pei Y; Ke Z; Huang L
    Front Pediatr; 2021; 9():655327. PubMed ID: 33968855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Persistent photopsia following course of oral voriconazole.
    Kadikoy H; Barkmeier A; Peck B; Carvounis PE
    J Ocul Pharmacol Ther; 2010 Aug; 26(4):387-8. PubMed ID: 20653481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. VORICONAZOLE TOXICITY IN MULTIPLE PENGUIN SPECIES.
    Hyatt MW; Georoff TA; Nollens HH; Wells RL; Clauss TM; Ialeggio DM; Harms CA; Wack AN
    J Zoo Wildl Med; 2015 Dec; 46(4):880-8. PubMed ID: 26667545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of multiple doses of voriconazole on the vision of healthy volunteers: a double-blind, placebo-controlled study.
    Zrenner E; Tomaszewski K; Hamlin J; Layton G; Wood N
    Ophthalmic Res; 2014; 52(1):43-52. PubMed ID: 24925440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic drug monitoring and safety of intravenous voriconazole formulated with sulfobutylether β-cyclodextrin in haematological patients with renal impairment.
    Kim SH; Kwon JC; Park C; Han S; Yim DS; Choi JK; Cho SY; Lee HJ; Park SH; Choi SM; Choi JH; Yoo JH; Lee DG; Lee JW
    Mycoses; 2016 Oct; 59(10):644-51. PubMed ID: 27324913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.